Summary: Apnimed Inc, a clinical-stage pharmaceutical company developing oral therapies for obstructive sleep apnea and other sleep disorders, will showcase findings from a recent clinical trial on obesity hypoventilation syndrome (OHS) at the European Respiratory Society (ERS) … [Read more...]
Sleep Monitoring Integrated into Phase 2 Obesity Drug Trial
Summary: Beacon Biosignals and Skye Bioscience are partnering to integrate sleep quality and sleep apnea endpoints in a phase 2 trial of obesity drug candidate Nimacimab. The trial will utilize sleep monitoring technology to provide an assessment of the drug’s impact on … [Read more...]
Boosting Sleep May Reduce Obesity Risk in Youth with ADHD
Summary: A study co-led by the University of Missouri found that unmedicated youth with ADHD have higher rates of obesity and are more likely to exceed screen time recommendations and fall short of sleep guidelines. The research analyzed data from a national survey of youths aged … [Read more...]
Night Shifts Disrupt Protein Rhythms, Increasing Obesity Risk
Summary: A analyze by Washington Condition University and the Pacific Northwest Countrywide Laboratory observed that just 3 times on a night time change schedule disrupts protein rhythms associated to blood glucose regulation, rate of metabolism, and inflammation—a disruption … [Read more...]